A detailed history of Macquarie Group LTD transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Macquarie Group LTD holds 359,541 shares of DGX stock, worth $49.3 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
359,541
Previous 382,449 5.99%
Holding current value
$49.3 Million
Previous $52.3 Million 5.85%
% of portfolio
0.05%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$137.09 - $137.09 $3.14 Million - $3.14 Million
-22,908 Reduced 5.99%
359,541 $49.3 Million
Q2 2024

Aug 09, 2024

SELL
$125.91 - $144.34 $4.08 Million - $4.68 Million
-32,440 Reduced 7.82%
382,449 $52.3 Million
Q1 2024

May 14, 2024

BUY
$123.78 - $142.11 $1.13 Million - $1.29 Million
9,107 Added 2.24%
414,889 $55.2 Million
Q4 2023

Feb 14, 2024

SELL
$120.62 - $141.12 $2.1 Million - $2.46 Million
-17,427 Reduced 4.12%
405,782 $55.9 Million
Q3 2023

Nov 14, 2023

SELL
$121.86 - $144.92 $648,051 - $770,684
-5,318 Reduced 1.24%
423,209 $51.6 Million
Q2 2023

Aug 14, 2023

BUY
$130.56 - $146.84 $33.4 Million - $37.5 Million
255,608 Added 147.82%
428,527 $60.2 Million
Q1 2023

May 15, 2023

SELL
$131.53 - $155.76 $2.33 Million - $2.76 Million
-17,701 Reduced 9.29%
172,919 $24.5 Million
Q4 2022

Feb 21, 2023

SELL
$123.31 - $157.26 $404,703 - $516,127
-3,282 Reduced 1.69%
190,620 $29.8 Million
Q3 2022

Nov 14, 2022

BUY
$121.77 - $141.1 $133,703 - $154,927
1,098 Added 0.57%
193,902 $23.8 Million
Q2 2022

Aug 15, 2022

SELL
$127.07 - $145.39 $84,120 - $96,248
-662 Reduced 0.34%
192,804 $25.6 Million
Q1 2022

May 16, 2022

SELL
$129.09 - $164.35 $50.8 Million - $64.6 Million
-393,357 Reduced 67.03%
193,466 $26.5 Million
Q4 2021

Feb 11, 2022

SELL
$140.36 - $173.01 $4.13 Million - $5.09 Million
-29,435 Reduced 4.78%
586,823 $102 Million
Q3 2021

Nov 12, 2021

BUY
$132.95 - $158.0 $1.39 Million - $1.66 Million
10,484 Added 1.73%
616,258 $89.5 Million
Q2 2021

Aug 13, 2021

BUY
$126.66 - $141.48 $48 Million - $53.6 Million
378,585 Added 166.64%
605,774 $79.9 Million
Q1 2021

May 14, 2021

SELL
$114.63 - $133.34 $511,708 - $595,229
-4,464 Reduced 1.93%
227,189 $29.2 Million
Q4 2020

Feb 16, 2021

SELL
$112.7 - $128.05 $1.33 Million - $1.51 Million
-11,766 Reduced 4.83%
231,653 $27.6 Million
Q3 2020

Nov 13, 2020

SELL
$107.05 - $130.01 $1.37 Million - $1.66 Million
-12,766 Reduced 4.98%
243,419 $27.9 Million
Q2 2020

Aug 11, 2020

SELL
$73.34 - $122.61 $13,054 - $21,824
-178 Reduced 0.07%
256,185 $29.2 Million
Q1 2020

May 15, 2020

BUY
$75.14 - $115.68 $198,670 - $305,857
2,644 Added 1.04%
256,363 $20.6 Million
Q4 2019

Feb 14, 2020

BUY
$100.29 - $107.99 $12.3 Million - $13.2 Million
122,245 Added 92.98%
253,719 $27.1 Million
Q3 2019

Nov 14, 2019

SELL
$97.85 - $107.42 $765 Million - $840 Million
-7,817,068 Reduced 98.35%
131,474 $14.1 Million
Q2 2019

Aug 14, 2019

SELL
$85.18 - $101.94 $10.3 Million - $12.3 Million
-120,335 Reduced 1.49%
7,948,542 $809 Million
Q1 2019

May 15, 2019

BUY
$80.68 - $89.92 $29.1 Million - $32.4 Million
360,327 Added 4.67%
8,068,877 $726 Million
Q4 2018

Feb 15, 2019

BUY
$79.75 - $108.38 $79.8 Million - $108 Million
1,000,318 Added 14.91%
7,708,550 $642 Million
Q3 2018

Nov 15, 2018

BUY
$105.42 - $114.99 $32.3 Million - $35.2 Million
306,017 Added 4.78%
6,708,232 $724 Million
Q2 2018

Aug 14, 2018

SELL
$97.35 - $113.14 $40.3 Million - $46.8 Million
-413,466 Reduced 6.07%
6,402,215 $704 Million
Q1 2018

May 11, 2018

SELL
$96.42 - $107.88 $4.11 Million - $4.59 Million
-42,588 Reduced 0.62%
6,815,681 $684 Million
Q4 2017

Feb 15, 2018

SELL
$90.86 - $100.24 $1.79 Million - $1.97 Million
-19,657 Reduced 0.29%
6,858,269 $675 Million
Q3 2017

Nov 08, 2017

BUY
$91.96 - $108.35 $632 Million - $745 Million
6,877,926
6,877,926 $644 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.